| The FDA is warning against use of the injectable form of dolasetron mesylate (Anzemet) to prevent nausea and vomiting in patients undergoing cancer chemotherapy, as new data indicate the drug can cause life-threatening cardiac arrhythmias. However, an oral form may … Continue reading |
|
The post Cancer nausea drug causes arrhythmias: FDA warning appeared first on Health, Medical, and Science Updates.